Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 5Targocid
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2014 Revenue in Millions : -2.40%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2015 Revenue in Millions : 178
2014 Revenue in Millions : 176
Growth (%) : -1%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2016 Revenue in Millions : 158
2015 Revenue in Millions : 170
Growth (%) : -7
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 161
2016 Revenue in Millions : 185
Growth (%) : -13
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2018 Revenue in Millions : 0
2017 Revenue in Millions : 147
Growth (%) : -100%
LOOKING FOR A SUPPLIER?